Information Provided By:
Fly News Breaks for March 17, 2016
HCA
Mar 17, 2016 | 08:42 EDT
Oppenheimer analyst Michael Wiederhorn remains a buyer of HCA Holdings' shares given "strong" Q4 results, a "robust" outlook, improved ACA enrollment trends, and an "attractive" valuation. The analyst reiterates his Outperform rating and $85 price target on the stock.
News For HCA From the Last 2 Days
There are no results for your query HCA